J.P. Morgan Reiterates Overweight Rating On Ariad Pharmaceuticals

27% profit every 20 days?

This is what Nic Chahine averages with his option buys. Not selling covered calls or spreads… BUYING options. Most traders don’t even have a winning percentage of 27% buying options. He has an 83% win rate. Here’s how he does it.

According to J.P. Morgan, Ariad Pharmaceuticals (NASDAQ: ARIA) Overweight rating is reiterated.J.P. Morgan said that it reiterates its OW rating on ARIA following Friday's very well attended R&D Day in NYC. “While ARIA shares could be volatile (along with the rest of biotech) over the summer months, we remain very comfortable with the company's intermediate to long-term outlook. We are establishing a prob-adj Dec 2012 PT of $13 (our prior Dec 2011 PT was $10).”Ariad Pharmaceuticals closed on Friday at $9.32.

27% profit every 20 days?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!